GRNJ - ETF AI Analysis

Top Page

Fundstrat Granny Shots US Small- & Mid-Cap ETF (GRNJ)

Rating:70Neutral

Price Target:―

The ETF GRNJ demonstrates a solid overall rating, driven by strong contributions from holdings like Dycom (DY) and Royal Gold (RGLD). Dycom stands out with its robust financial performance, positive earnings sentiment, and growth potential, while Royal Gold benefits from strong revenue growth, a debt-free balance sheet, and consistent dividend increases. However, weaker holdings such as Rocket Lab (RKLB), which faces profitability challenges and valuation concerns, may have slightly weighed on the fund's overall rating. A potential risk for the ETF is its exposure to companies with high valuations, which could impact performance during market downturns.

Positive Factors

Strong Sector Focus

The ETF has significant exposure to Industrials and Technology, which are sectors that often drive innovation and economic growth.

Broad Diversification Across Holdings

The fund's top holdings are well-distributed, with no single stock dominating the portfolio, reducing individual company risk.

Healthy Year-to-Date Performance

The ETF has delivered positive returns so far this year, indicating solid performance in its chosen market segments.

Negative Factors

High Expense Ratio

The ETF charges a relatively high expense ratio compared to many other funds, which can eat into investor returns over time.

Limited Geographic Exposure

With nearly all assets concentrated in the U.S., the fund lacks diversification across global markets, increasing vulnerability to domestic economic downturns.

Sector Concentration Risk

The ETF is heavily weighted in Industrials and Technology, which could lead to underperformance if these sectors face challenges.

GRNJ vs. SPDR S&P 500 ETF (SPY)

AUM252.35M

RegionNorth America

Expense Ratio0.75%

Beta1.75

IssuerFundstrat

Inception DateNov 18, 2025

Dividend YieldN/A

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume304,836

30 Day Avg. Volume452,511

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

30.95

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering53

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

GRNJ Summary

The Fundstrat Granny Shots US Small- & Mid-Cap ETF (GRNJ) is an actively managed fund that focuses on small- and mid-sized U.S. companies with high growth potential. It invests in a mix of 20 to 100 companies across industries like technology, industrials, and financials. Some well-known holdings include Rocket Lab USA and Albemarle. This ETF is ideal for investors looking to diversify their portfolios and tap into the growth opportunities of smaller, underrepresented companies. However, since it focuses on smaller companies, its value can be more volatile compared to funds that invest in larger, more established companies.

How much will it cost me?The GRNJ ETF has an expense ratio of 0.75%, which means you’ll pay $7.50 per year for every $1,000 invested. This is higher than the average for ETFs because it is actively managed, requiring more research and expertise to select investments.

What would affect this ETF?GRNJ could benefit from growth in the U.S. small- and mid-cap sectors, especially in industries like Industrials and Technology, which make up a significant portion of its holdings. Positive economic conditions, increased infrastructure spending, or advancements in technology could drive these sectors forward. However, rising interest rates or economic slowdowns could negatively impact smaller companies, as they often face higher borrowing costs and are more sensitive to market downturns.

GRNJ Top 10 Holdings

The GRNJ ETF is leaning heavily on industrials and technology, which together make up nearly 60% of its portfolio, showcasing a clear focus on innovation and infrastructure. Rocket Lab is rising on strong revenue growth and contract wins, while UiPath’s record profitability is adding momentum. On the flip side, Albemarle’s financial struggles and Dycom’s recent dip are holding back performance. With its U.S.-centric approach and emphasis on smaller, high-growth companies, GRNJ is a dynamic play for investors seeking exposure to emerging opportunities, though some holdings show mixed signals.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
RKLB	Rocket Lab USA	3.14%	$7.77M	$44.38B	208.73%	57 Neutral
LITE	Lumentum Holdings	2.56%	$6.32M	$24.69B	312.73%	61 Neutral
KTOS	Kratos Defense	2.52%	$6.23M	$17.57B	254.24%	60 Neutral
SN	SharkNinja, Inc.	2.39%	$5.92M	$17.35B	13.76%	76 Outperform
ALB	Albemarle	2.38%	$5.89M	$18.98B	82.95%	58 Neutral
RGLD	Royal Gold	2.33%	$5.76M	$20.69B	81.05%	78 Outperform
RDDT	Reddit Inc Class A	2.24%	$5.53M	$48.12B	51.99%	75 Outperform
ON	ON Semiconductor	2.23%	$5.53M	$24.50B	12.88%	73 Outperform
CCJ	Cameco	2.17%	$5.38M	$45.85B	114.78%	71 Outperform
WFRD	Weatherford International	2.16%	$5.35M	$6.40B	27.10%	72 Outperform

GRNJ Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

100DMA

200DMA

Market Momentum

MACD

0.46

Negative

RSI

61.45

Neutral

STOCH

88.65

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GRNJ, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 26.41, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.46 indicates Negative momentum. The RSI at 61.45 is Neutral, neither overbought nor oversold. The STOCH value of 88.65 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GRNJ.

GRNJ Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
GRNJ	―	―	$252.35M	0.75%	―
RSMC	―	―	$721.36M	0.75%	―
MSSM	―	―	$714.90M	0.57%	―
NBSM	―	―	$209.22M	0.65%	―
SMIZ	―	―	$174.80M	0.56%	―
MGMT	―	―	$160.36M	1.10%	―

Performance Comparison

GRNJ

Fundstrat Granny Shots US Small- & Mid-Cap ETF

27.28

2.70

10.98%

RSMC

Rockefeller U.S. Small-Mid Cap ETF

―

MSSM

Morgan Stanley Pathway Small-Mid Cap Equity ETF

―

NBSM

Neuberger Berman Small-Mid Cap ETF

―

SMIZ

Zacks Small/Mid Cap ETF

―

MGMT

Ballast Small/Mid Cap ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents